UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review

Viruses, 2023-10, Vol.15 (11), p.2197

2023

Volltextzugriff (PDF)

Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders

Chinese medical journal, 2023-09, Vol.136 (18), p.2147-2155

2023

Volltextzugriff (PDF)

The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives

Frontiers in immunology, 2023-01, Vol.13, p.1091543-1091543

2023

Volltextzugriff (PDF)

Mechanisms underlying the development of type 1 diabetes in ART-treated people living with HIV: an enigmatic puzzle

Frontiers in immunology, 2024-08, Vol.15, p.1470308

2024

Volltextzugriff (PDF)

Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature

Frontiers in immunology, 2022-02, Vol.13, p.828860-828860

2022

Volltextzugriff (PDF)

Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review

Frontiers in immunology, 2021-11, Vol.12, p.786341-786341

2021

Volltextzugriff (PDF)

HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis

Frontiers in microbiology, 2024-08, Vol.15, p.1428239

2024

Volltextzugriff (PDF)

Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection

Gut microbes, 2023-12, Vol.15 (1), p.2167171-2167171

2023

Volltextzugriff (PDF)

Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection

Frontiers in immunology, 2024, Vol.15, p.1390650

2024

Volltextzugriff (PDF)

Influence of HIV infection on cognition and overall intelligence in HIV-infected individuals: advances and perspectives

Frontiers in behavioral neuroscience, 2023-10, Vol.17, p.1261784-1261784

2023

Volltextzugriff (PDF)

HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection

Frontiers in immunology, 2022-04, Vol.13, p.853346-853346

2022

Volltextzugriff (PDF)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease

Journal of fungi (Basel), 2023-06, Vol.9 (6), p.647

2023

Volltextzugriff (PDF)

Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review

Frontiers in immunology, 2022-01, Vol.12, p.755890-755890

2022

Volltextzugriff (PDF)

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target

Frontiers in immunology, 2021-08, Vol.12, p.710121-710121

2021

Volltextzugriff (PDF)

Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure

Chinese medical journal, 2021-12, Vol.134 (23), p.2776-2787

2021

Volltextzugriff (PDF)

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

Frontiers in pharmacology, 2020-05, Vol.11, p.710-710

2020

Volltextzugriff (PDF)

HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance

Emerging microbes & infections, 2021-01, Vol.10 (1), p.1919-1930

2021

Volltextzugriff (PDF)

SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders

Frontiers in public health, 2022-08, Vol.10, p.945448

2022

Volltextzugriff (PDF)

The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China

Frontiers in pharmacology, 2020-05, Vol.11, p.800

2020

Volltextzugriff (PDF)

Gut microbiota: a potential key player in boosting immune reconstitution of immunological nonresponders

Future microbiology, 2023-01, Vol.18 (2), p.83-85

2023

Volltextzugriff (PDF)

Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report

Chinese medical journal, 2020-12, Vol.133 (23), p.2803-2807

2020

Volltextzugriff (PDF)

CRF01_AE and CRF01_AE Cluster 4 Are Associated With Poor Immune Recovery in Chinese Patients Under Combination Antiretroviral Therapy

Clinical infectious diseases, 2021-05, Vol.72 (10), p.1799-1809

2021

Volltextzugriff (PDF)

HIV Gene Therapy Strategies and Safety: What do we know from the Recent Publications?

AIDS reviews, 2020-10, Vol.23 (3), p.195-202

2020

Volltextzugriff (PDF)

Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China

HIV medicine, 2022-03, Vol.23 (S1), p.84-94

2022

Volltextzugriff (PDF)

The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV

Probiotics and antimicrobial proteins, 2024-08, Vol.16 (4), p.1465-1482

2024

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)
Berichte
(1)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review

Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders

The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives

Mechanisms underlying the development of type 1 diabetes in ART-treated people living with HIV: an enigmatic puzzle

Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature

Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review

HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis

Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection

Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection

Influence of HIV infection on cognition and overall intelligence in HIV-infected individuals: advances and perspectives

HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease

Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target

Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance

SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders

The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China

Gut microbiota: a potential key player in boosting immune reconstitution of immunological nonresponders

Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report

CRF01_AE and CRF01_AE Cluster 4 Are Associated With Poor Immune Recovery in Chinese Patients Under Combination Antiretroviral Therapy

HIV Gene Therapy Strategies and Safety: What do we know from the Recent Publications?

Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China

The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV

Suchergebnisse filtern